Reassessing standard neoadjuvant gemcitabine plus S-1 for resectable pancreatic head cancer: a retrospective cohort study.

Kimura K, Sato S, Naito Z, Yamamoto H, Suzuki T, Kyogoku N, Katagiri H, Yamabuki T, Kato K, Takada M, Ambo Y, Hirano S

DOI: 10.21037/jgo-2026-0892
Published: 2026 Oct 30
Container: Journal of gastrointestinal oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/jgo-2026-0892,
  title = {Reassessing standard neoadjuvant gemcitabine plus S-1 for resectable pancreatic head cancer: a retrospective cohort study.},
  author = {Kimura K and Sato S and Naito Z and Yamamoto H and Suzuki T and Kyogoku N and Katagiri H and Yamabuki T and Kato K and Takada M and Ambo Y and Hirano S},
  year = {2026},
  journal = {Journal of gastrointestinal oncology},
  doi = {10.21037/jgo-2026-0892},
  url = {https://doi.org/10.21037/jgo-2026-0892}
}

RIS

TY  - JOUR
TI  - Reassessing standard neoadjuvant gemcitabine plus S-1 for resectable pancreatic head cancer: a retrospective cohort study.
AU  - Kimura K
AU  - Sato S
AU  - Naito Z
AU  - Yamamoto H
AU  - Suzuki T
AU  - Kyogoku N
AU  - Katagiri H
AU  - Yamabuki T
AU  - Kato K
AU  - Takada M
AU  - Ambo Y
AU  - Hirano S
PY  - 2026
JO  - Journal of gastrointestinal oncology
DO  - 10.21037/jgo-2026-0892
UR  - https://doi.org/10.21037/jgo-2026-0892
ER  -

APA

K, K., S, S., Z, N., H, Y., T, S., N, K., H, K., T, Y., K, K., M, T., Y, A., & S, H. (2026). Reassessing standard neoadjuvant gemcitabine plus S-1 for resectable pancreatic head cancer: a retrospective cohort study.. Journal of gastrointestinal oncology. https://doi.org/10.21037/jgo-2026-0892

Source records

pubmed · retrieved 2026-11-10T11:31:32.004Z